Avidity Biosciences, Inc.
RNA
$49.77
-$1.00-1.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 144.56% | -47.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 144.56% | -47.09% | |||
| Cost of Revenue | 38.83% | 4.04% | |||
| Gross Profit | -37.13% | -5.68% | |||
| SG&A Expenses | 9.71% | 18.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.48% | 7.36% | |||
| Operating Income | -30.13% | -8.70% | |||
| Income Before Tax | -35.88% | -13.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.88% | -13.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.88% | -13.22% | |||
| EBIT | -30.13% | -8.70% | |||
| EBITDA | -30.29% | -8.72% | |||
| EPS Basic | -35.46% | -12.58% | |||
| Normalized Basic EPS | -35.47% | -12.57% | |||
| EPS Diluted | -34.84% | -13.09% | |||
| Normalized Diluted EPS | -35.47% | -12.57% | |||
| Average Basic Shares Outstanding | 0.30% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||